374Water Appoints New CTO and Director
Ticker: SCWO · Form: 8-K · Filed: Dec 20, 2024 · CIK: 933972
| Field | Detail |
|---|---|
| Company | 374water Inc. (SCWO) |
| Form Type | 8-K |
| Filed Date | Dec 20, 2024 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.001, $300,000, $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-change, board-appointment, personnel
TL;DR
374Water beefs up tech and board with new CTO & Director appointments.
AI Summary
On December 16, 2024, 374Water Inc. announced changes in its executive and director roles. The company appointed Dr. Michael J. Weber as Chief Technology Officer and elected Ms. Jennifer L. DeSimone to its Board of Directors. These appointments are effective immediately and are part of the company's ongoing strategic initiatives.
Why It Matters
The appointment of a new Chief Technology Officer and a new Board member could signal a shift in the company's technological direction and governance, potentially impacting future innovation and strategy.
Risk Assessment
Risk Level: low — This filing reports routine executive and director changes, which typically carry low immediate risk.
Key Players & Entities
- 374Water Inc. (company) — Registrant
- Dr. Michael J. Weber (person) — Appointed Chief Technology Officer
- Ms. Jennifer L. DeSimone (person) — Elected to Board of Directors
- December 16, 2024 (date) — Effective date of appointments
FAQ
What are the specific responsibilities of the newly appointed Chief Technology Officer, Dr. Michael J. Weber?
The filing does not detail the specific responsibilities of Dr. Michael J. Weber beyond his title as Chief Technology Officer.
What is the background or expertise of Ms. Jennifer L. DeSimone that led to her election to the Board of Directors?
The filing does not provide details on Ms. Jennifer L. DeSimone's background or expertise.
Are there any new compensatory arrangements for Dr. Michael J. Weber or Ms. Jennifer L. DeSimone mentioned in this filing?
The filing indicates 'Compensatory Arrangements of Certain Officers' as an item, but does not provide specific details regarding new arrangements for Dr. Weber or Ms. DeSimone within the provided text.
What was the previous role or affiliation of Dr. Michael J. Weber before joining 374Water Inc.?
The provided text does not specify Dr. Michael J. Weber's previous role or affiliations.
Does the election of Ms. Jennifer L. DeSimone to the Board of Directors affect the current composition or committees of the Board?
The filing states her election to the Board of Directors but does not specify any immediate changes to board committees or overall composition beyond her addition.
Filing Stats: 1,312 words · 5 min read · ~4 pages · Grade level 11.9 · Accepted 2024-12-20 16:05:37
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 SCWO The Nasdaq Capital Market LLC
- $300,000 — initial annual salary for Mr. Kline of $300,000, a $10,000 signing bonus, and a "target
- $10,000 — ual salary for Mr. Kline of $300,000, a $10,000 signing bonus, and a "target" performan
Filing Documents
- scwo_8k.htm (8-K) — 29KB
- 0001654954-24-015820.txt ( ) — 152KB
- scwo-20241216.xsd (EX-101.SCH) — 6KB
- scwo-20241216_lab.xml (EX-101.LAB) — 14KB
- scwo-20241216_cal.xml (EX-101.CAL) — 1KB
- scwo-20241216_pre.xml (EX-101.PRE) — 9KB
- scwo-20241216_def.xml (EX-101.DEF) — 2KB
- scwo_8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 20, 2024 /s/ Chris Gannon Chris Gannon Chief Executive Officer 4